Research Article
Redox Metabolism-Associated Molecular Classification of Clear Cell Renal Cell Carcinoma
Table 1
Clinicopathological characteristics between three clusters in TCGA cohort.
| Characteristics | Cluster 1 (n, %) | Cluster 2 (n, %) | Cluster 3 (n, %) | value |
| Age | | | | 0.348 | >65 | 62 (36.9%) | 66 (36.1%) | 54 (30.2%) | | ≤65 | 106 (63.1%) | 117 (63.9%) | 125 (69.8%) | | Gender | | | | 0.574 | Male | 110 (65.5%) | 123 (67.2%) | 111 (62%) | | Female | 58 (34.5%) | 60 (32.8%) | 68 (38%) | | T stage | | | | 0.116 | T1 | 92 (54.6%) | 84 (45.9%) | 85 (53.1%) | | T2 | 17 (10.1%) | 23 (12.6%) | 29 (16.2%) | | T3 | 54 (33.5%) | 70 (38.2) | 53 (29.6%) | | T4 | 3 (1.8%) | 6 (3.3%) | 2 (1.1%) | | N stage | | | | 0.281 | N0 | 83 (49.4%) | 76 (41.5%) | 80 (44.7%) | | N1 | 3 (1.8%) | 9 (4.9%) | 4 (2.2%) | | Nx | 82 (48.8%) | 98 (53.6%) | 95 (53.1%) | | M stage | | | | 0.521 | M0 | 140 (83.3%) | 146 (79.8%) | 154 (86%) | | M1 | 24 (14.3%) | 34 (18.6%) | 22 (12.3%) | | Mx | 4 (2.4%) | 3 (1.6%) | 3 (1.7%) | | AJCC stage | | | | 0.059 | Stage I | 90 (53.6%) | 81 (44.3%) | 95 (53.1%) | | Stage II | 13 (7.7%) | 17 (9.3%) | 27 (15.1%) | | Stage III | 40 (23.8%) | 49 (26.8%) | 35 (19.6%) | | Stage IV | 25 (14.9%) | 36 (19.7%) | 22 (12.3%) | | Grade | | | | 0.024 | G1 | 4 (2.4%) | 3 (1.6%) | 7 (3.9%) | | G2 | 60 (35.7%) | 76 (41.5%) | 93 (52%) | | G3 | 78 (46.4%) | 70 (38.3%) | 59 (33%) | | G4 | 25 (14.9%) | 33 (18%) | 17 (9.5%) | | Gx | 1 (0.6%) | 1 (0.5%) | 3 (0.9%) | |
|
|